(Q24234168)

title

Azithromycin for treating uncomplicated malaria (English)

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

14 May 2020

Dianne J Terlouw

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

author name string

Anna M van Eijk

series ordinal

1

0 references

Dianne J Terlouw

series ordinal

2

0 references

publication date

16 February 2011

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

14 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

14 May 2020

page(s)

CD006688

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Therapeutic responses to antibacterial drugs in vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Antimalarial dosing regimens and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Evolution of a new drug formulation: the rationale for high-dose, short-course therapy with azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Antimalarial drugs in pregnancy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Macrolides: structures and microbial targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Allocation concealment in randomised trials: defending against deciphering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Antimalarial Drug Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

The assessment of antimalarial drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006688.PUB2

Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery

21 January 2018

1 reference

12 December 2020

A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand.

1 reference

12 December 2020

In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.

1 reference

12 December 2020

A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria

1 reference

12 December 2020

Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro

1 reference

12 December 2020

Randomized, controlled, double-blind trial of daily oral azithromycin in adults for the prophylaxis of Plasmodium vivax malaria in Western Thailand.

1 reference

12 December 2020

A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.

1 reference

12 December 2020

Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study.

1 reference

12 December 2020

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia

1 reference

12 December 2020

Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study

1 reference

12 December 2020

Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo.

1 reference

12 December 2020

Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei

1 reference

12 December 2020

Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria

1 reference

12 December 2020

10.1002/14651858.CD006688.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6532599&resulttype=core&format=json

14 May 2020

PubMed publication ID

21328286

1 reference